Sanofi Aktie
105,74
EUR
-0,90
EUR
-0,84
%
105,88
EUR
-1,38
EUR
-1,29
%
Kursziele der Sanofi-Aktie in EUR
Kurs
Ø Kursziel
BUY
HOLD
SELL
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Goldman Sachs Group Inc. | 120,00 EUR | +13,34% | 21.03.2025 | |
| Bernstein Research | 114,00 EUR | +7,67% | 11.03.2025 | |
| Jefferies & Company Inc. | 120,00 EUR | +13,34% | 10.03.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 120,00 EUR | +13,34% | 05.03.2025 | |
| Deutsche Bank AG | 100,00 EUR | -5,55% | 04.03.2025 | |
| JP Morgan Chase & Co. | 110,00 EUR | +3,89% | 14.02.2025 | |
| UBS AG | 120,00 EUR | +13,34% | 13.02.2025 | |
| DZ BANK | - | - | 31.01.2025 | |
| Barclays Capital | 120,00 EUR | +13,34% | 23.09.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | - |
| Bayer | 1 | 8 | 0 | 24,88 EUR | +3,24% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +38,05% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | +52,68% |
| GSK PLC Registered Shs | 2 | 6 | 1 | 16,62 GBP | +10,14% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 180,57 EUR | +37,11% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +106,15% |
| MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,12 CHF | -0,11% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,20 USD | +14,92% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +9,09% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |